The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications
Open accessAbstract
Hypertriglyceridemia is a risk factor for atherosclerotic coronary heart disease. Very high triglyceride (TG) levels (> or =500 mg/dl [5.65 mmol/l]) increase the risk of pancreatitis. One therapeutic option to lower TG levels is omega-3 fatty acids, which are derived from the oil of fish and other seafood. The American Heart Association has acknowledged that fish oils may decrease dysrhythmias, decrease sudden death, decrease the rate of atherosclerosis and slightly lower blood pressure, and has recommended fish consumption or fish oil supplementation as a therapeutic strategy to reduce cardiovascular disease. A prescription omega-3-acid ethyl esters (P-OM3) preparation has been available in many European nations for at least a decade, and was approved by the US FDA in 2004 to reduce very high TG levels (> or =500 mg/dl [5.65 mmol/l]). Mechanistically, most evidence suggests that omega-3 fatty acids reduce the synthesis and secretion of very-low-density lipoprotein (VLDL) particles, and increase TG removal from VLDL and chylomicron particles through the upregulation of enzymes, such as lipoprotein lipase. Omega-3 fatty acids differ mechanistically from other lipid-altering drugs, which helps to explain why therapies such as P-OM3 have complementary mechanisms of action and, thus, complementary lipid benefits when administered with statins. Additional human studies are needed to define more clearly the cellular and molecular basis for the TG-lowering effects of omega-3 fatty acids and their favorable cardiovascular effects, particularly in patients with hypertriglyceridemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Effects ofn-3 fatty acids on cartilage metabolism
Curtis, C. L., Rees, S., Cramp, J., Flannery, C. R., Hughes, C., Little, C. B., Williams, R., Wilson, C., Dent, C., Harwood, J. L., et al. (2002) · Proceedings of The Nutrition Society · doi:10.1079/pns2002174 · Cited by 65
RetractedDetection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Global strategy on diet, physical activity and health
Samuelson, G. (2004) · Food & Nutrition Research · doi:10.3402/fnr.v48i2.1503 · Cited by 2,319
(1999) · PubMed · Cited by 2,062
Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases
Simopoulos, A. P. (2002) · Journal of the American College of Nutrition · doi:10.1080/07315724.2002.10719248 · Cited by 2,009
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits
Mozaffarian, D., & Rimm, E. B. (2006) · JAMA · doi:10.1001/jama.296.15.1885 · Cited by 1,966
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
Essential fatty acids in health and chronic disease
Simopoulos, A. P. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.560s · Cited by 1,692
Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408
n-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243
Distribution, interconversion, and dose response of n-3 fatty acids in humans.
Arterburn, L. M., Hall, E. B., & Oken, H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1467s · Cited by 1,162
Stampfer, M. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110036029 · Cited by 1,079
Hypertriglyceridemia as a cardiovascular risk factor
Austin, M. A., Hokanson, J. E., & Edwards, K. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00031-9 · Cited by 1,066
Gardner, C. D., Kiazand, A., Alhassan, S., Kim, S., Stafford, R. S., Balise, R. R., Kraemer, H. C., & King, A. C. (2007) · JAMA · doi:10.1001/jama.297.9.969 · Cited by 1,051
The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina
SanGiovanni, J. P., & Chew, E. Y. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.06.002 · Cited by 874
The Framingham Offspring Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Kompendium der Lipid-Studien · doi:10.1007/978-3-642-95642-3_25 · Cited by 831
He, K., Song, Y., Daviglus, M. L., Liu, K., Van Horn, L., Dyer, A. R., & Greenland, P. (2004) · Circulation · doi:10.1161/01.cir.0000132503.19410.6b · Cited by 764
Bays, H., Mandarino, L., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030723 · Cited by 664
Self-citationEtiopathogenesis of Nonalcoholic Steatohepatitis
Chitturi, S., & Farrell, G. C. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12927 · Cited by 661
The Biochemistry of n-3 Polyunsaturated Fatty Acids
Jump, D. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100062200 · Cited by 636
Hypertriglyceridemia: its etiology, effects and treatment
Yuan, G., Al-Shali, K. Z., & Hegele, R. A. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060963 · Cited by 624
Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., O’Neal, D. N., Best, J. D., & Beilin, L. J. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1085 · Cited by 588
Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice
Horton, J. D., Bashmakov, Y., Shimomura, I., & Shimano, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5987 · Cited by 577
Role of apoCs in lipoprotein metabolism: functional differences between apoC1, apoC2, and apoC3
Jong, M. C., Hofker, M. H., & Havekes, L. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.472 · Cited by 539
Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes
Ginsberg, H. N., Zhang, Y.-L., & Hernandez-Ono, A. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.005 · Cited by 531
Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study
Meigs, J. B., D'Agostino, R. B., Wilson, P. W., Cupples, L. A., Nathan, D. M., & Singer, D. E. (1997) · Diabetes · doi:10.2337/diabetes.46.10.1594 · Cited by 527
Yoshikawa, T., Shimano, H., Amemiya-Kudo, M., Yahagi, N., Hasty, A. H., Matsuzaka, T., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.2991-3000.2001 · Cited by 526
Bays, H. E., Chapman, R. H., Grandy, S., & the SHIELD Investigators’ Group (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01336.x · Cited by 510
Self-citationSacks, F. M., Alaupovic, P., Moye, L. A., Cole, T. G., Sussex, B., Stampfer, M. J., Pfeffer, M. A., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1886 · Cited by 490
Lin, P.-Y., & Su, K.-P. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0712 · Cited by 481
Diet as a risk factor for atopy and asthma
Devereux, G., & Seaton, A. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.12.1139 · Cited by 470
Fish Intake and Risk of Incident Atrial Fibrillation
Mozaffarian, D., Psaty, B. M., Rimm, E. B., Lemaitre, R. N., Burke, G. L., Lyles, M. F., Lefkowitz, D., & Siscovick, D. S. (2004) · Circulation · doi:10.1161/01.cir.0000138154.00779.a5 · Cited by 456
Issues in Hyperlipidemic Pancreatitis
Yadav, D., & Pitchumoni, C. S. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200301000-00016 · Cited by 435
Yoshikawa, T., Shimano, H., Yahagi, N., Ide, T., Amemiya-Kudo, M., Matsuzaka, T., Nakakuki, M., Tomita, S., Okazaki, H., Tamura, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105711200 · Cited by 425
(1995) · PubMed · Cited by 423
Omega-3 fatty acids and inflammation
Mori, T. A., & Beilin, L. J. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0087-5 · Cited by 421
Why do omega-3 fatty acids lower serum triglycerides?
Harris, W. S., & Bulchandani, D. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000236363.63840.16 · Cited by 398
Davidson, M. H., Stein, E. A., Bays, H. E., Maki, K. C., Doyle, R. T., Shalwitz, R. A., Ballantyne, C. M., & Ginsberg, H. N. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.018 · Cited by 385
Self-citationMechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty Acids
Davidson, M. H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.024 · Cited by 374
Self-citationRaitt, M. H., Connor, W. E., Morris, C., Kron, J., Halperin, B., Chugh, S. S., McClelland, J., Cook, J., MacMurdy, K., Swenson, R., et al. (2005) · JAMA · doi:10.1001/jama.293.23.2884 · Cited by 371
Amminger, G. P., Berger, G. E., Schäfer, M. R., Klier, C., Friedrich, M. H., & Feucht, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.007 · Cited by 355
Prospective study of dietary fat and the risk of age-related macular degeneration
Cho, E., Hung, S., Willett, W. C., Spiegelman, D., Rimm, E. B., Seddon, J. M., Colditz, G. A., & Hankinson, S. E. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.209 · Cited by 350
Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance
Park, Y., & Harris, W. S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200282-jlr200 · Cited by 348
n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review
Nettleton, J. A., & Katz, R. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.11.029 · Cited by 339
Kast, H. R., Nguyen, C. M., Sinal, C. J., Jones, S. A., Laffitte, B. A., Reue, K., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0712 · Cited by 336
Weintraub, M. S., Zechner, R., Brown, A., Eisenberg, S., & Breslow, J. L. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113806 · Cited by 331
Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression
Kitajka, K., Sinclair, A. J., Weisinger, R. S., Weisinger, H. S., Mathai, M., Jayasooriya, A. P., Halver, J. E., & Puskás, L. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402342101 · Cited by 313
Activation of PPARδ alters lipid metabolism in db/db mice
Leibowitz, M. D., Fiévet, C., Hennuyer, N., Peinado-Onsurbe, J., Duez, H., Berger, J., Cullinan, C. A., Sparrow, C. P., Baffic, J., Berger, G. D., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01554-4 · Cited by 308
Safety and Efficacy of Omacor in Severe Hypertriglyceridemia
Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L., & Osmundsen, K. (1997) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679700400511 · Cited by 306
Kawakami, A., Aikawa, M., Alcaide, P., Luscinskas, F. W., Libby, P., & Sacks, F. M. (2006) · Circulation · doi:10.1161/circulationaha.106.622514 · Cited by 305
Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
Shachter, N. S. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00009 · Cited by 288
Bourre, J. M. (2004) · PubMed · Cited by 288
Terry, P. D., Rohan, T. E., & Wolk, A. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.3.532 · Cited by 285
Alessandri, J.-M., Guesnet, P., Vancassel, S., Astorg, P., Denis, I., Langelier, B., Aïd, S., Poumès-Ballihaut, C., Champeil-Potokar, G., & Lavialle, M. (2004) · Reproduction Nutrition Development · doi:10.1051/rnd:2004063 · Cited by 283
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
Claudel, T., Inoue, Y., Barbier, O., Duran-Sandoval, D., Kosykh, V., Fruchart, J., Fruchart, J.-C., Gonzalez, F. J., & Staels, B. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00896-5 · Cited by 268
n‐3 fatty acids and lipoproteins: Comparison of results from human and animal studies
Harris, W. S. (1996) · Lipids · doi:10.1007/bf02529870 · Cited by 264
Omega-3 Fatty Acids in the Treatment of Psychiatric Disorders
Peet, M., & Stokes, C. (2005) · Drugs · doi:10.2165/00003495-200565080-00002 · Cited by 258
A Model of Insulin Resistance and Nonalcoholic Steatohepatitis in Rats
Svegliati-Baroni, G., Candelaresi, C., Saccomanno, S., Ferretti, G., Bachetti, T., Marzioni, M., De Minicis, S., Nobili, L., Salzano, R., Omenetti, A., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050953 · Cited by 256
New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism
Ginsberg, H. N. (2002) · Circulation · doi:10.1161/01.cir.0000035280.64322.31 · Cited by 255
Schneeman, B. O., Kotite, L., Todd, K. M., & Havel, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.2069 · Cited by 255
Safety and efficacy of Omacor in severe hypertriglyceridemia
Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L., & Osmundsen, K. (1997) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199710000-00011 · Cited by 252
Omega-3 fatty acids and neuropsychiatric disorders
Young, G., & Conquer, J. (2005) · Reproduction Nutrition Development · doi:10.1051/rnd:2005001 · Cited by 251
Cartwright, I. J., Pockley, A. G., Galloway, J. H., Greaves, M., & Preston, F. E. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90106-6 · Cited by 247
Safety Considerations with Omega-3 Fatty Acid Therapy
Bays, H. E. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.020 · Cited by 234
Self-citationAbe, Y., El-Masri, B., Kimball, K. T., Pownall, H., Reilly, C. F., Osmundsen, K., Smith, C. W., & Ballantyne, C. M. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.5.723 · Cited by 214
Ribeiro Barros Cardoso, C., Aparecida Souza, M., Amália Vieira Ferro, E., Favoreto, S., & Deolina Oliveira Pena, J. (2004) · Wound Repair and Regeneration · doi:10.1111/j.1067-1927.2004.012216.x · Cited by 207
Hopkins, P. N., Heiss, G., Ellison, R. C., Province, M. A., Pankow, J. S., Eckfeldt, J. H., & Hunt, S. C. (2003) · Circulation · doi:10.1161/01.cir.0000081777.17879.85 · Cited by 207
Rivellese, A. A., Maffettone, A., Vessby, B., Uusitupa, M., Hermansen, K., Berglund, L., Louheranta, A., Meyer, B. J., & Riccardi, G. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00424-0 · Cited by 198
Expert Opinion: Omega-3 Fatty Acids and Bleeding—Cause for Concern?
Harris, W. S. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.021 · Cited by 191
Suzukawa, M., Abbey, M., Howe, P. R., & Nestel, P. J. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39881-3 · Cited by 185
Pownall, H. J., Brauchi, D., Kilinç, C., Osmundsen, K., Pao, Q., Payton-Ross, C., Gotto, A. M., & Ballantyne, C. M. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00301-3 · Cited by 179
Long-term Follow-up of Patients With Acute Hypertriglyceridemia-Induced Pancreatitis
Athyros, V. G., Giouleme, O. I., Nikolaidis, N. L., Vasiliadis, T. V., Bouloukos, V. I., Kontopoulos, A. G., & Eugenidis, N. P. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200204000-00020 · Cited by 177
Mack, W. J., Krauss, R. M., & Hodis, H. N. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.5.697 · Cited by 174
Frost, L., & Vestergaard, P. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.50 · Cited by 173
Pharmacotherapy for dyslipidaemia – current therapies and future agents
Bays, H., & Stein, E. A. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.11.1901 · Cited by 172
Self-citationHypertriglyceridemia-induced pancreatitis: A case-based review
Gan, S. I. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i44.7197 · Cited by 168
Omega-3 fatty acid monotherapy for pediatric bipolar disorder: A prospective open-label trial
Wozniak, J., Biederman, J., Mick, E., Waxmonsky, J., Hantsoo, L., Best, C., Cluette-Brown, J. E., & Laposata, M. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.11.006 · Cited by 166
Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period
Heath, R. B., Karpe, F., Milne, R. W., Burdge, G. C., Wootton, S. A., & Frayn, K. N. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300167-jlr200 · Cited by 163
Abbey, M., Clifton, P., Kestin, M., Belling, B., & Nestel, P. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.1.85 · Cited by 162
Digiacomo, R. A., Kremer, J. M., & Shah, D. M. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90261-1 · Cited by 162
Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia
Schrepf, R., Limmert, T., Weber, P. C., Theisen, K., & Sellmayer, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16105-9 · Cited by 160
Chan, D. C., Watts, G. F., Barrett, P. H. R., Beilin, L. J., Redgrave, T. G., & Mori, T. A. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2377 · Cited by 160
Lipoprotein metabolism and its relationship to atherosclerosis
Ginsberg, H. N. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30174-2 · Cited by 157
Cohn, J. S., Marcoux, C., & Davignon, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2474 · Cited by 156
Veenkamp (2002) · doi:10.1161/hq0202.104059 · Cited by 152
Multiple sclerosis and nutrition
Schwarz, S. T., & Leweling, H. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1119oa · Cited by 151
Alteration of polyunsaturated fatty acid status and metabolism in health and disease
Zamaria, N. (2004) · annales de biologie animale biochimie biophysique · doi:10.1051/rnd:2004034 · Cited by 147
Khan, S., Minihane, A.-M., Talmud, P. J., Wright, J. W., Murphy, M. C., Williams, C. M., & Griffin, B. A. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30473-9 · Cited by 145
Kaminski, W., Jendraschak, E., Kiefl, R., & von Schacky, C. (1993) · Blood · doi:10.1182/blood.v81.7.1871.1871 · Cited by 145
Wilkinson, P. M. H., Leach, C., Ah-Sing, E., Hussain, N., Miller, G. J., Millward, D. J., & Griffin, B. A. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.029 · Cited by 140
Eicosapentaenoic Acid Induces mRNA Expression of Peroxisome Proliferator‐Activated Receptor γ
Chambrier, C., Bastard, J., Rieusset, J., Chevillotte, E., Bonnefont‐Rousselot, D., Thérond, P., Hainque, B., Riou, J. P., Laville, M., & Vidal, H. (2002) · Obesity Research · doi:10.1038/oby.2002.70 · Cited by 139
Polyunsaturated Fatty Acids Are FXR Ligands and Differentially Regulate Expression of FXR Targets
Zhao, A., Yu, J., Lew, J.-L., Huang, L., Wright, S. D., & Cui, J. (2004) · DNA and Cell Biology · doi:10.1089/1044549041562267 · Cited by 139
New and classical risk factors--the Münster heart study (PROCAM).
Assmann, G., Schulte, H., & Cullen, P. (1997) · PubMed · Cited by 139
Dyslipidemia in Visceral Obesity: Mechanisms, Implications, and Therapy
Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404040-00004 · Cited by 134
Calabresi, L., Villa, B., Canavesi, M., Sirtori, C. R., James, R. W., Bernini, F., & Franceschini, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.09.007 · Cited by 132
Low density lipoprotein size, pravastatin treatment, and coronary events.
Campos, H. (2001) · JAMA · doi:10.1001/jama.286.12.1468 · Cited by 132
Influence of Plasma Free Fatty Acids on Lipoprotein Synthesis and Diabetic Dyslipidemia
Julius, U. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-41284 · Cited by 131
Dietary omega-3 Fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging.
Bourre, J. M. (2005) · PubMed · Cited by 131
Clinical Overview of Omacor: A Concentrated Formulation of Omega-3 Polyunsaturated Fatty Acids
Bays, H. E. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.029 · Cited by 130
Self-citationEffect of α linolenic acid on cardiovascular risk markers: a systematic review
Wendland, E., Farmer, A., Glasziou, P., & Neil, A. (2006) · Heart · doi:10.1136/hrt.2004.053538 · Cited by 128
Prophylaxis of Hemodialysis Graft Thrombosis with Fish Oil
Schmitz, P. G., McCloud, L. K., Reikes, S. T., Leonard, C. L., & Gellens, M. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131184 · Cited by 127
Albino, A. P., Juan, G., Traganos, F., Reinhart, L., Connolly, J. M., Rose, D. P., & Darżynkiewicz, Z. (2000) · PubMed · Cited by 125
Ingelsson, E., SULLIVAN, L. M., Murabito, J. M., Fox, C. S., Benjamin, E. J., Polak, J. F., Meigs, J. B., Keyes, M. J., O’Donnell, C. J., Wang, T. J., et al. (2007) · Diabetes · doi:10.2337/db07-0078 · Cited by 123
The farnesoid X receptor induces very low density lipoprotein receptor gene expression
Sirvent, A., Claudel, T., Martin, G., Brozek, J., Kosykh, V., Darteil, R., Hum, D. W., Fruchart, J., & Staels, B. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.026 · Cited by 122
Ginsberg, H. N., Le, N., & Gibson, J. C. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111739 · Cited by 122
The role of omega-3 fatty acids in cardiovascular disease
von Schacky, C. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0086-y · Cited by 118
Mayer, K., Merfels, M., Muhly-Reinholz, M., Gokorsch, S., Rosseau, S., Lohmeyer, J., Schwarzer, N., Krüll, M., Suttorp, N., Grimminger, F., et al. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00235.2002 · Cited by 116
Bays, H. E., Blonde, L., & Rosenson, R. S. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.6.871 · Cited by 114
Self-citationManagement of Acute Severe Hyperlipidemic Pancreatitis
Kyriakidis, A. V., Raitsiou, B., Sakagianni, A., Harisopoulou, V., Pyrgioti, M., Panagopoulou, A., Vasilakis, N., & Lambropoulos, S. (2006) · Digestion · doi:10.1159/000095425 · Cited by 113
Vanschoonbeek, K., Feijge, M. A. H., Paquay, M. M., Rosing, J., Saris, W. H. M., Kluft, C., Giesen, P. L. A., de Maat, M. P. M., & Heemskerk, J. W. M. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000137119.28893.0b · Cited by 111
Terry, P., Terry, J., & Rohan, T. E. (2004) · Journal of Nutrition · doi:10.1093/jn/134.12.3412s · Cited by 110
Adiposopathy: Sick Fat Causes High Blood Sugar, High Blood Pressure and Dyslipidemia
Bays, H. E., Abate, N. I., & Chandalia, M. (2005) · Future Cardiology · doi:10.1517/14796678.1.1.39 · Cited by 109
Self-citationAyyobi, A. F., & Brunzell, J. D. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00613-1 · Cited by 106
Hepatic farnesyl diphosphate synthase expression is suppressed by polyunsaturated fatty acids
Jossic-Corcos, C. L., Gonthier‐Guéret, C., Zaghini, I., Logette, E., Shechter, I., & Bournot, P. (2005) · Biochemical Journal · doi:10.1042/bj20040933 · Cited by 103
Nordøy, Bønaa, Nilsen, Berge, Hansen, & Ingebretsen (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00297.x · Cited by 103
Miller, M., Ginsberg, H. N., & Schaefer, E. J. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.046 · Cited by 102
Stalenhoef, A. F. H., Graaf, J. D., Wittekoek, M. E., Bredie, S. J. H., Demacker, P. N. M., & Kastelein, J. J. P. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00381-6 · Cited by 101
Millar, J. S., Stone, S. J., Tietge, U. J. F., Tow, B., Billheimer, J. T., Wong, J. S., Hamilton, R. L., Farese, R. V., & Rader, D. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600213-jlr200 · Cited by 100
MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment
Puri, B. K., Bydder, G. M., Counsell, S. J., Corridan, B., Richardson, A. J., Hajnal, J. V., Appel, C., McKee, H. M., Vaddadi, K. S., & Horrobin, D. F. (2002) · Neuroreport · doi:10.1097/00001756-200201210-00029 · Cited by 100
Influence of dietary carbohydrate and fat on LDL and HDL particle distributions
Siri, P. W., & Krauss, R. M. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0062-9 · Cited by 99
The role of omega-3 fatty acids in cardiac protection: an overview
Hassan, M. I. (2005) · Frontiers in bioscience · doi:10.2741/1601 · Cited by 95
Vine, D. F., Takechi, R., Russell, J. C., & Proctor, S. D. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.013 · Cited by 88
Westphal, S., Orth, M., Ambrosch, A., Osmundsen, K., & Luley, C. H. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.4.914 · Cited by 87
Adiposopathy: why do adiposity and obesity cause metabolic disease?
Bays, H. E., & Ballantyne, C. M. (2006) · Future Lipidology · doi:10.2217/17460875.1.4.389 · Cited by 86
Self-citationThe role of fish oil/omega-3 fatty acids in the treatment of IgA nephropathy
Donadío, J. V., & Grande, J. P. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.01.004 · Cited by 85
Wilson, D. E., Hata, A., Kwong, L. K., Lingam, A. T., Shuhua, J., Ridinger, D. N., Yeager, C., KALTENBORN, K. C., Iverius, P., & Lalouel, J.-M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116551 · Cited by 85
Postprandial lipoprotein metabolism, genes and risk of cardiovascular disease
López‐Miranda, J., Pérez‐Martínez, P., Marín, C., Moreno, J. A., Gómez, P., & Pérez‐Jiménez, F. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000217894.85370.c2 · Cited by 82
Williams, C. M., Moore, F., Morgan, L., & Wright, J. (1992) · British Journal of Nutrition · doi:10.1079/bjn19920123 · Cited by 81
Management of hypertriglyceridemia.
Oh, R., & Lanier, J. B. (2007) · PubMed · Cited by 78
Essential fatty acids in health and chronic diseases.
Simopoulos, A. P. (2003) · PubMed · Cited by 78
Postprandial lipemia: An under-recognized atherogenic factor in patients with diabetes mellitus
Pastromas, S. C., Terzi, A. B., Tousoulis, D., & Koulouris, S. N. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.04.172 · Cited by 76
Apolipoprotein E and familial dysbetalipoproteinemia: Clinical, biochemical, and genetic aspects
Smelt, A. H. M., & de Beer, F. (2004) · Seminars in Vascular Medicine · doi:10.1055/s-2004-861492 · Cited by 73
n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.
Christensen, J. H. (2003) · PubMed · Cited by 70
Apolipoprotein B Versus Non–High-Density Lipoprotein Cholesterol: And the Winner Is…
Sniderman, A. D. (2005) · Circulation · doi:10.1161/circulationaha.105.583336 · Cited by 70
Dagnelie, P. C., Rietveld, T., Swart, G. R., & Stijnen, T. (1994) · Lipids · doi:10.1007/bf02537089 · Cited by 69
Saldeen, P., & Saldeen, T. G. P. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000140038.70473.96 · Cited by 69
Bender, N., Kraynak, M., Chiquette, E., Linn, W., Clark, G. M., & Bussey, H. (1998) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1008852127668 · Cited by 67
Dietary polyunsaturated fatty acids in asthma- and exercise-induced bronchoconstriction
Mickleborough, T. D., & Rundell, K. W. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602250 · Cited by 66
Dietary fat and postprandial lipids
Sanders, T. A. B. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0034-x · Cited by 62
Lu, G., Windsor, S. L., & Harris, W. S. (1999) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(98)00094-1 · Cited by 61
Vakkilainen, J., Jauhiainen, M., Ylitalo, K., Nuotio, I. O., Viikari, J. S. A., Ehnholm, C., & Taskinen, M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31489-9 · Cited by 61
Parks, J. S., Johnson, F., Wilson, M., & Rudel, L. L. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43167-0 · Cited by 59
Effect of exercise duration on postprandial hypertriglyceridemia in men with metabolic syndrome
Zhang, J. Q., Ji, L. L., Fogt, D. L., & Fretwell, V. S. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00181.2007 · Cited by 58
N-3 fatty acids and pregnancy outcomes
Décsi, T., & Koletzko, B. V. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200503000-00009 · Cited by 55
Gazvani, M. R., Smith, L., Haggarty, P., Fowler, P., & Templeton, A. A. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01991-4 · Cited by 52
A pilot open case series of Ethyl-EPA supplementation in the treatment of anorexia nervosa
Ayton, A. K., Azaz, A., & Horrobin, D. F. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.03.007 · Cited by 51
Clinical efficacy of n-3 fatty acid supplementation in patients with asthma
Wong, K. W. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.10.009 · Cited by 50
Are omega-3 fatty acids the most important nutritional modulators of coronary heart disease risk?
Harris, W. S. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0085-7 · Cited by 47
Logan, A. C. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.941-b · Cited by 47
Collins, N., Tighe, A. P., Brunton, S. A., & Kris-Etherton, P. M. (2008) · Journal of the American College of Nutrition · doi:10.1080/07315724.2008.10719743 · Cited by 44
Self-citationEffects of Exercise in Overweight Japanese with Multiple Cardiovascular Risk Factors
Nishijima, H., Satake, K., Igarashi, K., Morita, N., KANAZAWA, N., & Okita, K. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3180383d84 · Cited by 44
Marcoux, C., Hopkins, P. N., Wang, T., Leary, E. T., Nakajima, K., Davignon, J., & Cohn, J. S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33455-6 · Cited by 43
Treatment of Hypertriglyceridemia With Omega‐3 Fatty Acids: A Systematic Review
Lewis, A., Lookinland, S., Beckstrand, R. L., & Tiedeman, M. E. (2004) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2004.tb00388.x · Cited by 43
GENETICS OF LIPOPROTEIN DISORDERS
Davignon, J., & Genest, J. J. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70024-4 · Cited by 41
n−3 fatty acids, heart rate variability, and sudden cardiac death
Christensen, J. H., & Schmidt, E. B. (2001) · Lipids · doi:10.1007/s11745-001-0693-9 · Cited by 40
Unraveling the complex genetics of familial combined hyperlipidemia
Suviolahti, E., Lilja, H. E., & Pajukanta, P. (2006) · Annals of Medicine · doi:10.1080/07853890600865759 · Cited by 39
Severe hypertriglyceridemia-induced pancreatitis during pregnancy.
Gürsoy, A., Kulaksızoğlu, M., Sahin, M., Ertuğrul, D. T., Ozer, F., Tütüncü, N. B., & Demirağ, N. G. (2006) · PubMed Central · Cited by 38
Jap, T., Jenq, S.-F., Wu, Y.-C., Chiu, C. T., & Cheng, H.-M. (2003) · Pancreas · doi:10.1097/00006676-200308000-00003 · Cited by 38
von Schacky, C., Baumann, K., & Angerer, P. (2001) · Lipids · doi:10.1007/s11745-001-0689-5 · Cited by 37
Sethi, S. M. (2002) · Redox Report · doi:10.1179/135100002125001144 · Cited by 36
Brunton, S., & Collins, N. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x188017 · Cited by 36
Biological mechanisms and cardiovascular effects of omega-3 fatty acids.
Mueller, B. A., & Talbert, R. L. (1988) · PubMed · Cited by 36
Fat Modification in the Diabetes Diet
Julius, U. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-39230 · Cited by 35
Validity of the Aphasia Item from the Scandinavian Stroke Scale
Thommessen, B., Thoresen, G. E., Bautz‐Holter, E., & Laake, K. (2002) · Cerebrovascular Diseases · doi:10.1159/000047773 · Cited by 34
Zaima, N., Sugawara, T., Goto, D., & Hirata, T. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600273-jlr200 · Cited by 33
Durrington, P. N. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.401 · Cited by 30
Fish Oil, Atherogenesis, and Thrombogenesisa
Kim, D. N., Eastman, A. Y., BAKER, J. E., Mastrangelo, A. M., Sethi, S. M., Ross, J. S., Schmee, J., & Thomas, W. A. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb17343.x · Cited by 30
The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters
Bryhn, M., Hansteen, H., Schanche, T., & Aakre, S. E. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.04.003 · Cited by 28
Torcetrapib/atorvastatin combination therapy
Bays, H. E., McKenney, J. M., & Davidson, M. H. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.5.789 · Cited by 28
Self-citationCommon problems in the management of hypertriglyceridemia.
Fung, M. A., & Frohlich, J. J. (2002) · Europe PMC (PubMed Central) · Cited by 28
Kramer, J. A., Butteiger, D. N., Young, T., Crankshaw, C. L., Kier, L. D., Bhat, B. G., LeDeaux, J. R., & Harlow, H. F. (2003) · Journal of Nutrition · doi:10.1093/jn/133.1.57 · Cited by 28
Ricco, J. (1990) · Journal of Vascular Surgery · doi:10.1016/0741-5214(90)90229-4 · Cited by 27
Is there a case for n-3 fatty acid supplementation in cystic fibrosis?
Cawood, A. L., Carroll, M. P., Wootton, S. A., & Calder, P. C. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200503000-00008 · Cited by 26
Dietary Omega-3 Polyunsaturated Fatty Acid Supplementation and Airway Hyperresponsiveness in Asthma
Mickleborough, T. D. (2005) · Journal of Asthma · doi:10.1081/jas-200062950 · Cited by 25
Polyunsaturated fatty acids and risk of preterm delivery.
Facchinetti, F., Fazzio, M., & Venturini, P. (2005) · PubMed · Cited by 23
Nauck, M., Nissen, H., Hoffmann, M. M., Herwig, J., Pullinger, C. R., Averna, M. R., Geisel, J., Wieland, H., & März, W. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.7.1388 · Cited by 22
Severe Hypertriglyceridemia, large lipoproteins and protection against atherosclerosis
Nordestgaard, B. G., Stender, S., & Kjeldsen, K. (1987) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365518709168149 · Cited by 21
Demystifying triglycerides: a practical approach for the clinician.
Dunbar, R. L., & Rader, D. J. (2005) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.72.8.661 · Cited by 20
McKeone, B. J., Osmundsen, K., Brauchi, D., Pao, Q., Payton‐Ross, C., Kilinç, C., Kummerow, F. A., & Pownall, H. J. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37251-5 · Cited by 19
Geelen, A., Zock, P. L., Brouwer, I. A., Katan, M., Kors, J. A., van Eck, H. J. R., & Schouten, E. G. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20051429 · Cited by 17
Marschang, P., Götsch, C., Kirchmair, R., Kaser, S., Kähler, C. M., & Patsch, J. R. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.07.014 · Cited by 14
Hypertriglyceridemia and Coronary Heart Disease
Jones, J. D. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.2.189 · Cited by 11
Effects of dietary fat intake in sudden death: Reduction of death with omega-3 fatty acids
Lee, K. W., Hamaad, A., MacFadyen, R. J., & Lip, G. Y. H. (2004) · Current Cardiology Reports · doi:10.1007/s11886-004-0040-9 · Cited by 11
Nagasaka, H., Kikuta, H., Chiba, H., Murano, T., Harashima, H., Ohtake, A., Senzaki, H., Sasaki, N., Inoue, I., Katayama, S., et al. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-002-1133-3 · Cited by 11
García-Otín, A. L., Civeira, F., Peinado‐Onsurbe, J., Gonzalvo, C., Llobera, M., & Pocoví, M. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410502 · Cited by 10
Cited by
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
Lavie, C. J., Milani, R. V., Mehra, M. R., & Ventura, H. O. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.084 · Cited by 644
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association
Bays, H. E., Toth, P. P., Kris-Etherton, P. M., Abate, N., Aronne, L. J., Brown, W. V., Gonzalez-Campoy, J. M., Jones, S. R., Kumar, R., La Forge, R., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.04.001 · Cited by 521
Self-citation
Metadata
- Authors
- Bays, H. E., Tighe, A. P., Sadovsky, R., & Davidson, M. H.
- Venue
- Expert Review of Cardiovascular Therapy
- Publisher
- Informa UK Limited
- Published
- 2008-03
- Volume
- 6
- Issue
- 3
- Pages
- 391-409
- ISSN
- 1477-9072 (ISSN-L)
- 1744-8344
- OpenAlex
- W1998826672
- Cited by
- 265
- References
- 191
- FWCI
- 17.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.